Skip to main content
. 2020 Jul 6;4(2):rkaa029. doi: 10.1093/rap/rkaa029

Fig. 1.

Fig. 1

Discontinuation rates of the allocated treatments by Kaplain–Meier analysis

The discontinuation rates of the allocated treatments attributable to any reasons (a) and attributable to adverse events (b) are shown. Cumulative treatment discontinuation rates were compared using the log-rank test among groups. ES: escalation group; HS: half-strength dosage group; SS: single-strength dosage group.